Tous Actualités
Suivre
Abonner november AG

november AG

euro adhoc: november AG
Liquidity Problems/Over-Indebtedness
IBL Hamburg AG files for insolvency

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
20.12.2007
Erlangen, 20 December 2007. The Hamburg based IBL Gesellschaft für 
Immunchemie und Immunbiologie mbH, a 100% subsidiary of the Erlangen 
based development and holding company november AG (ISIN DE000A0S9N72)
has filed for insolvency today, 20 December 2007, with the local 
court of Hamburg because of illiquidity and on-balance sheet 
over-indebtedness. This is because the ongoing negotiations with 
different banks relating to different loans could not be concluded in
time before the expiry of the insolvency deadline.
end of announcement                               euro adhoc

Further inquiry note:

Marcus Weichert
november AG - Public Relations/Investor Relations
Ulrich-Schalk-Str. 3, D-91056 Erlangen
Tel.: +49 (0)9131 750 88 868
e-mail: weichert@november.de, www.november.de

Branche: Biotechnology
ISIN: DE000A0S9N72
WKN: A0S9N7
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse Hannover / free trade
Börse München / free trade

Plus de actualités: november AG
Plus de actualités: november AG